This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, National Institute of Health and Medical Research, Université Grenoble Alpes. Active years: 2019-2022.
Company Filing History:
2 out of 8,807 
1 out of 1,853 
1 out of 177 
Years Active: 2019-2022
Title: Catherine Pillet: Innovator in Cancer Treatment
Introduction
Catherine Pillet is a notable inventor based in Vif, France. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing novel therapeutic approaches for various cancers.
Latest Patents
Catherine's latest patents include groundbreaking inventions aimed at treating cancers, including Cushing disease. One of her patents, titled "Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease," concerns the use of heterocyclic naphthoquinones derivatives to inhibit Ubiquitin Specific Proteases (USP) 8 and/or 2. Another significant patent is "Synthetic lethal drug combination for treating renal cell carcinoma," which presents a novel treatment approach for renal cell carcinoma and other solid tumors with VHL inactivation. This invention combines a first agent that inhibits protein kinase CK2 and a second agent that inhibits Ataxia Telangiectasia Mutated (ATM) kinase.
Career Highlights
Catherine has worked with prestigious organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the National Institute of Health and Medical Research. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Throughout her career, Catherine has collaborated with esteemed colleagues, including Emmanuelle Soleilhac and Caroline Barette. These partnerships have enriched her research and fostered innovation in her field.
Conclusion
Catherine Pillet is a pioneering inventor whose work in cancer treatment has the potential to make a significant impact on patient care. Her innovative patents and collaborations highlight her dedication to advancing medical science.